Regarding AD pathogenesis, miRNAs have been shown to target molecular pathways associated with pathologic processes that are implicated in disease evolution, such as synaptic and mitochondrial dysfunction, Aβ accumulation, and tau toxicity. Here, MAPT is linked to Alzheimer disease.